EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Profiling of Polish Pediatric Patients with Epilepsy: A Single-Center Diagnostic Experience Using Next-Generation Sequencing

Beata Chałupczyńska iD, Elżbieta Ciara iD, Paulina Halat-Wolska iD, Agnieszka Pollak iD, Piotr Stawiński, Dorota Jurkiewicz, Dorota Piekutowska-Abramczuk, Marzena Gawlik, Justyna Pietrasik, Agata Cieślikowska iD, Dorota Wicher iD, Agata Ulatowska und 7 weitere

Genes · 2026

DOI: 10.3390/genes17020133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Beata Chałupczyńska und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, The Children's Memorial Health Institute, Member of the European Reference Network ITHACA, 04-730 Warsaw, Poland. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Epilepsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CMHI, MEiN, CMHI, MEiN.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Epilepsy syndromes show marked clinical and genetic heterogeneity, with numerous functionally diverse genes involved in their etiology. Next-generation sequencing (NGS) has facilitated the identification of many monogenic epilepsy syndromes and enables earlier, more accurate diagnosis in pediatric patients. Materials and Methods: This study analyzes the molecular profiles of 87 pediatric patients with various forms of epilepsy in whom pathogenic or likely pathogenic variants were identified. Next-generation sequencing (NGS) using multi-gene epilepsy panels or whole-exome sequencing (WES) was performed.

Results

A total of 88 pathogenic or likely pathogenic variants were detected in 48 epilepsy-related genes; 30 variants occurred de novo. SCN1A and KCNQ2 were the most frequent contributors (12.6% and 9.2%, respectively). The highest percentage of positive diagnoses (48%) was observed in patients with developmental and epileptic encephalopathy (DEE), with variants identified in genes including ALG13, ATP1A2, CACNA1A, CDKL5, CHD2, GABRG2, ITPA, KCNQ2, PCDH19, SCN1A, SCN2A, SCN3A, SCN8A, SMC1A, SPTAN1, STXBP1, and UBA5. Pathogenic variants in ANKRD11 were found in four patients with KBG syndrome, while other genes appeared sporadically.

Conclusions

Targeted massively parallel sequencing is an effective diagnostic tool for pediatric epilepsy. The presence of numerous single-case findings highlights the high genetic heterogeneity of epilepsy. This approach enabled more precise diagnoses that would not have been achieved through clinical evaluation alone, underscoring the importance of genetic testing for prognosis and treatment planning in pediatric patients with unexplained epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingEpilepsyHumansFemaleMaleChildChild, PreschoolNAV1.1 Voltage-Gated Sodium ChannelKCNQ2 Potassium ChannelInfantPolandMutationAdolescentExome SequencingGenetic Testing

Stichwörter der Autor:innen

Dravet syndromedevelopmental and epileptic encephalopathyepilepsygenetic testingmolecular profilenext-generation sequencingpediatric populationrare disease

Substanzen

NAV1.1 Voltage-Gated Sodium ChannelKCNQ2 Potassium ChannelKCNQ2 protein, humanSCN1A protein, human

Autor:innen und Institutionen

  • Department of Medical Genetics, The Children's Memorial Health Institute, Member of the European Reference Network ITHACA, 04-730 Warsaw, Poland.
  • Department of Medical Genetics, Warsaw Medical University, 02-106 Warsaw, Poland.
  • Department of Neurology and Epileptology, The Children's Memorial Health Institute, Member of the European Reference Network EpiCARE, 04-730 Warsaw, Poland.

ORCID-Profile: Beata Chałupczyńska, Elżbieta Ciara, Paulina Halat-Wolska, Agnieszka Pollak, Agata Cieślikowska, Dorota Wicher, Dorota Dunin-Wąsowicz, Krystyna Chrzanowska, Agnieszka Madej-Pilarczyk

Förderung

  • CMHI, MEiN
  • CMHI
  • MEiN

Zitieren

APA

Chałupczyńska, B., Ciara, E., Halat-Wolska, P., Pollak, A., Stawiński, P., Jurkiewicz, D., Piekutowska-Abramczuk, D., Gawlik, M., Pietrasik, J., Cieślikowska, A., Wicher, D., Ulatowska, A., Jedlińska, D., Borkowska, J., Chmielewski, D., Dunin-Wąsowicz, D., Kotulska-Jóźwiak, K., Chrzanowska, K., & Madej-Pilarczyk, A. (2026). Molecular Profiling of Polish Pediatric Patients with Epilepsy: A Single-Center Diagnostic Experience Using Next-Generation Sequencing. Genes. https://doi.org/10.3390/genes17020133

Vancouver

Chałupczyńska B, Ciara E, Halat-Wolska P, Pollak A, Stawiński P, Jurkiewicz D, et al. Molecular Profiling of Polish Pediatric Patients with Epilepsy: A Single-Center Diagnostic Experience Using Next-Generation Sequencing. Genes. 2026. doi:10.3390/genes17020133

BibTeX
@article{Chaupczyska2026,
  author = {Chałupczyńska, Beata and Ciara, Elżbieta and Halat-Wolska, Paulina and Pollak, Agnieszka and Stawiński, Piotr and Jurkiewicz, Dorota and Piekutowska-Abramczuk, Dorota and Gawlik, Marzena and Pietrasik, Justyna and Cieślikowska, Agata and Wicher, Dorota and Ulatowska, Agata and Jedlińska, Dominika and Borkowska, Julita and Chmielewski, Dariusz and Dunin-Wąsowicz, Dorota and Kotulska-Jóźwiak, Katarzyna and Chrzanowska, Krystyna and Madej-Pilarczyk, Agnieszka},
  title = {Molecular Profiling of Polish Pediatric Patients with Epilepsy: A Single-Center Diagnostic Experience Using Next-Generation Sequencing},
  journal = {Genes},
  year = {2026},
  doi = {10.3390/genes17020133}
}
Kostenlos starten →